Medical Weight Loss Treatment for Michigan Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Michigan Board of Medicine for comprehensive telehealth services across both peninsulas.
Whether you're in Detroit, Lansing, or anywhere across Michigan — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Michigan
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Michigan spans two peninsulas, thousands of miles of Great Lakes shoreline, and communities as diverse as downtown Detroit and the remote Upper Peninsula. OmniRx Health serves all of it. Whether you're in the automotive heart of Metro Detroit, the craft beer culture of Grand Rapids, the cherry orchards of Traverse City, or the wilderness of the UP, our telehealth platform brings expert care to you. No more planning around the Mackinac Bridge or seasonal road closures.
Available Treatments in Michigan
Our board-certified providers in Michigan can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Michigan
State Licensing
OmniRx Health providers are licensed by the Michigan Board of Medicine for comprehensive telehealth services across both peninsulas.
Telehealth Law
Michigan's telehealth laws support virtual care delivery with provisions for both synchronous and asynchronous services.
Pharmacy Access
Michigan pharmacies in Detroit, Grand Rapids, Traverse City, and throughout the UP ensure prescription access with statewide delivery.
Insurance Notes
Michigan requires commercial insurers to cover telehealth, and the state has expanded Medicaid telehealth coverage for eligible residents.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Michigan
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.